Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of colistin-induced kidney injury
IRCT20150721023282N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in acute kidney failure (AKF) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Serum creatinine, Blood urea nitrogen and 3 more. Started Sep 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20150721023282N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150721023282N6.